Skip to main content
. 2020 Jan 17;10:537. doi: 10.1038/s41598-019-57287-w

Figure 3.

Figure 3

Effect of novel mAb KU44.22B on the growth of Capan-2 human pancreatic cancer cells determined by SRB assay as described in Methods. Novel mAb KU44.22B inhibits the growth of Capan-2 human pancreatic cancer cells with IC50 = 4.5 nM.